Science Center

What Science Center does

The University City Science Center (Science Center) is a 501(c)(3) nonprofit innovation intermediary founded in 1963 and headquartered at 3675 Market Street in Philadelphia. It is the oldest and largest urban research park in the United States, operating the uCity Square knowledge community in partnership with Wexford Science + Technology and Ventas (20 buildings, 4.4M square feet, 15,000+ researchers, 200 businesses). The organization serves healthcare and medtech startups, investors, K-12 students, and healthcare ecosystem leaders by operating a portfolio of programs that translate life-science innovations into commercialized healthcare solutions.

The Science Center's core technology contribution is the Translation Project, an operating system launched in August 2025 that maps evidence gaps and aligns clinicians, payors, regulators, and investors to accelerate startup adoption. Programmatic offerings include the Capital Readiness Program (a free, competitive 5-day intensive cohort for medtech startups with at least $500K raised, having served 110 companies across 11 cohorts); CHESS clinical advisory ($15,000 per 3-month engagement led by CMO Kevin Baumlin MD plus four physician-advisors); Federal Funding Support (SBIR/STTR proposal development); the Founders Fellowship (NIH NIA-funded aging-market program); the U.S. Market Access Program for international companies; Venture Fellows Program; Medtech Builder Series; Physician Innovator Series; FirstHand STEM education (315 students, 49 schools, 143 mentors in 2025); and signature convenings including Think Tanks, Venture Café Philadelphia, and the Nucleus Awards.

The business model is a nonprofit platform-plus-programs structure. Primary revenue consists of restricted grants from government agencies (NIH, EDA, NIST, SBA) and corporate foundations (Genentech $300K Feb 2026; Genentech-funded Translation Council; EDA $902K Sep 2024; NIST $200K RAMPS grant Sep 2025), program fees (CHESS at $15K per 3-month engagement, Quorum event space rental), individual and corporate donations, and a Donor Advised Fund. No equity is taken from program participants. GTM is event-driven and content-led, anchored by the uCity Square physical infrastructure and amplified through partnerships with Penn Medicine, Siemens Healthineers, Hackensack Meridian Health, ARPA-H leadership, and a 65-member Investor Network representing $1.35B in venture capital. Identified alumni outcomes include $143M+ in capital raised cumulatively, $102M raised in 2025, 122 jobs created in 2025, and a Brookings-attributed $7.8B annual economic impact in Greater Philadelphia.

Name

Science Center

Legal name

University City Science Center

Website

https://sciencecenter.org

Company type

Private

Founded year

1963

Operating status

Operating

Headcount range

101–250 employees

Ownership category

akta.pro rank

Product category

Healthcare Innovation and Startup Commercialization Services

NAICS

Other Scientific and Technical Consulting Services (54169), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Educational Services (8200)

akta.pro primary industry

Health & Medical Research Grantmaking Foundations (BPAGAKAL)

akta.pro secondary industries

Research & Science Grantmaking Foundations (BPAGAKAI), Hands-on Science Exploration & Experiments (Lab Kits, Science Clubs) (EDAMABAA)

Keywords

• Healthcare innovation programs
• Startup commercialization services
• Medtech accelerator programs
• Clinical advisory services
• STEM workforce education

Headquarters

HQ city

Philadelphia

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Others, Infrastructure, Marketing or Sales, Technology or R&D

Revenue model

1. Grant Funding & Philanthropic Revenue: As a 501(c)(3) nonprofit, the Science Center's primary revenue consists of grants from government agencies (NIH, EDA, NIST, SBA), corporate foundations (Genentech/Roche Group), and other funders. These grants support specific programs such as the Founders Fellowship, Translation Project, FirstHand STEM education, and Capital Readiness Program. Revenue is restricted to designated programs.
2. Program Fees (CHESS): The CHESS (Clinicians for Healthcare Excellence and Startup Success) program charges $15,000 for a three-month engagement providing clinical advisors and expert network access to healthcare startups. This represents a fee-for-service revenue stream.
3. Event Sponsorship & Space Rental: Quorum Event Space generates revenue through rental of flexible meeting and event space at 3675 Market Street. The Nucleus Awards and other signature events offer sponsorship opportunities for corporate partners.
4. Individual & Corporate Giving: Individual donations and corporate membership/sponsorship packages support the Science Center's free programming. Corporate partnerships are customized by the Advancement team. The Science Center also operates a Donor Advised Fund (SC DAF) providing sustainable mission-aligned investments with returns flowing back into the fund.

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels8 records

Core offering

The Science Center operates as an innovation intermediary running a portfolio of programs that prepare medtech, digital health, and life sciences startups for commercialization and scale. Core paid and free offerings include the Capital Readiness Program (5-day cohort for first institutional fundraise preparation), CHESS clinical advisory engagements, Federal Funding Support (SBIR/STTR proposal development), the U.S. Market Access Program for international companies entering the U.S., and FirstHand STEM education for Philadelphia youth, all unified under the proprietary Translation Project™ operating framework.

Product overview

The Science Center (University City Science Center) is an innovation intermediary that operates as a platform-plus-programs model rather than a single unified product. The core Translation Project serves as the overarching operating system for moving life science and health tech innovations to market, supported by a portfolio of distinct programs including: Capital Readiness Program (5-day intensive for startups raising institutional capital), CHESS (clinical advisory service), Federal Funding Support (SBIR/STTR proposal development), Founders Fellowship (aging market startup support), U.S. Market Access Program (international company entry support), Venture Fellows Program (investor training), Medtech Builder Series, and Physician Innovator Series. STEM education is delivered through FirstHand. The ecosystem is supported by Venture Café Philadelphia gatherings, Quorum event space, ic@3401 incubator workspace, and The Nucleus Awards annual event. The organization drives approximately $7.8 billion in annual economic impact in Greater Philadelphia and has supported hundreds of life sciences companies.

Differentiator

Problem solved

Functional benefit

Brands

• FirstHand: STEM education program nurturing a 21st century STEM workforce to create a more equitable talent pipeline
• Translation Project
• Capital Readiness Program
• Quorum
• Venture Café Philadelphia
• CHESS (Clinicians for Healthcare Excellence and Startup Success)
• Nucleus Awards
• ic@3401

Products and services

• Capital Readiness Program A competitive 5-day intensive cohort program preparing medtech, digital health, and healthcare technology startups (with at least $500K already raised) for their first institutional fundraise of $1M\u2013$5M through due diligence preparation, investor feedback, mock board meetings, and strategic guidance. Free for selected participants; no equity taken.
• CHESS (Clinicians for Healthcare Excellence and Startup Success) Paid three-month clinical advisory engagement ($15,000) providing healthcare startups with dedicated clinical advisors (led by Chief Medical Affairs Officer Kevin Baumlin MD and a panel of additional clinicians), weekly working sessions, up to 8 hours of dedicated advisor access per month, and targeted introductions to healthcare system stakeholders.
• Federal Funding Support Comprehensive SBIR/STTR Technical and Business Assistance (TABA) including proposal development and award management services for startups and academic researchers pursuing federal research funding.
• Venture Fellows Program Program teaching participants to think like investors and understand the operating realities of founders in the healthcare innovation ecosystem.
• Founders Fellowship Program Fellowship supporting academic researchers in developing and commercializing solutions for the aging market, funded by an NIH NIA grant.
• U.S. Market Access Program Program supporting global medtech, diagnostics, device, and digital health companies entering the U.S. market through a virtual engagement phase and in-person immersion in Philadelphia, with annual showcase at the HLTH USA pavilion.
• FirstHand STEM Education Program Hands-on STEM education program for Philadelphia K-12 students (especially from underrepresented communities) featuring experiments, design prototypes, industry mentor meetings, micro-internships, and career sprints. Served 315 students from 49 schools in 2025 with 143 mentors and $25K in stipends.
• Translation Project Proprietary operating framework mapping evidence gaps, aligning stakeholders (clinicians, payors, regulators, investors), and connecting founders to pilots and partners to accelerate healthcare innovation translation and adoption.
• Medtech Builder Series Monthly in-person sessions equipping medtech founders with practical hands-on guidance focused on challenges that stall or derail startups, featuring expert-led working sessions with actionable takeaways.
• Physician Innovator Series Quarterly peer forum for physicians interested in engaging with medtech startups as clinical advisors, CMOs, or investors, providing insight exchange and relationship building with the healthcare innovation community.
• Venture Caf\u00e9 Philadelphia Weekly community gathering operated by the Science Center as part of the Venture Caf\u00e9 Global Network, offering content programming, networking, and opportunities for the innovation community.
• Quorum Event Space 15,000 sq ft flexible event space at 3675 Market Street including the Quorum Lounge (free and open to all) and six conference rooms available for rent for meetings, events, and gatherings.
• The Nucleus Awards Annual celebration event recognizing leaders fostering an innovative, collaborative, and equitable future in healthcare innovation, featuring cocktail reception, award ceremony, and networking with 250+ attendees.
• ic@3401 Incubator Workspace Collaborative workspace operated in partnership with Drexel University at 3401 Market Street, home to 30+ early-stage tech companies accommodating research, prototype, and pre-revenue stage companies.
• Healthcare Innovation Translation Council Council bringing together C-suite leaders across the healthcare ecosystem (clinicians, payors, regulators, investors) to accelerate healthcare innovation translation and patient impact. Funded by Genentech (Roche Group).

Quantifiable outcome

• $143M+ capital raised by Capital Readiness alumni companies
• +10 more outcomes

Named customers14 records

Segments6 records

Ideal customer profiles6 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature1 record

Partnerships

31 partnerships are on record, tiered core and minor.

• Hackensack Meridian HealthcoreStrategic or Co-development Partner · 1 September 2025SpotItEarly (Science Center-supported company) entered a partnership with Hackensack Meridian Health to advance research on early breast cancer detection. The partnership involves the Hennessy Institute for Cancer Prevention and Applied Molecular Medicine, the John Theurer Cancer Center, and Hackensack University Medical Center, launching the PINK Study — a large, multi-center, double-blind observational trial enrolling 2,000 participants.
• PA House Speaker Joanna McClinton and Representative Amen BrownminorOthers · 1 September 2025PA House Speaker McClinton and Representative Brown attended the FirstHand Showcase for students from Rhoads School and met with Science Center leadership to discuss the role of the Science Center in supporting and growing the life sciences industry in Philadelphia.
• National AcademiesminorStrategic or Co-development Partner · 1 September 2025The FirstHand team and AnLar presented a poster at the National Academies Convocation on the Status of Informal Science and Engineering Education in Washington, D.C., highlighting how FirstHand's informal STEM education program leverages cross-sector collaboration.
• Atrium Health / The Pearl (Charlotte, NC)minorStrategic or Co-development Partner · 1 June 2025The Science Center was engaged in 2024 by a new innovation district in Charlotte, NC to share expertise in developing industry-informed STEM education. In June 2025, The Pearl opened as a public-private partnership led by Atrium Health, Wexford Science & Technology, and Ventas. Science Center's FirstHand programming was adapted for 20 middle school innovators at The Pearl in November 2025.
• SelectUSA / Chamber of Commerce for Greater PhiladelphiaminorGTM or Marketing Partner · 1 May 2025The Science Center welcomed 20 international health tech startup leaders from over a dozen countries for a panel discussion on collaborating with health systems in Greater Philadelphia, as part of SelectUSA Investment Summit spinoff tour co-hosted with Delaware Prosperity Partnership and Choose New Jersey.
• InBIA (International Business Innovation Association)minorStrategic or Co-development Partner · 1 April 2025The Science Center led an ecosystem tour of uCity Square for 70 attendees during the ICBI39 InBIA Global Conference in Philadelphia in April 2025, in partnership with CIC and Wexford.
• WHYYminorGTM or Marketing Partner · 1 April 2025WHYY covered the FirstHand student showcase for its April 'You Oughta Know' segment, where students debuted their latest tech innovations.
• Oslo Science CityminorStrategic or Co-development Partner · 1 March 2025A delegation of 25 public- and private-sector leaders from Norway, guided by the Norwegian government, visited uCity Square in March 2025 to learn about curating tenant mixes, activating spaces, and designing environments that foster collaboration and economic growth.
• Team Pennsylvania FoundationminorStrategic or Co-development Partner · 1 March 2025The Science Center hosted Team Pennsylvania's Board of Directors (30 leaders from across the Commonwealth's public and private sectors) for a meeting and guided tour of 3675 Market Street. Team Pennsylvania is a statewide organization aligning strategic public and private investments to accelerate PA's economic growth.
• Ventas, Inc. (NYSE: VTR)coreStrategic or Co-development Partner · 1 January 2016Ventas joined the uCity Square partnership alongside the Science Center and Wexford Science + Technology in 2016, contributing to the development of a knowledge community spanning 20 buildings and 4.4M square feet in Philadelphia's University City district.
• Wexford Science + TechnologycoreStrategic or Co-development Partner · 1 January 2015The Science Center entered into a joint partnership with Wexford Science + Technology (and Ventas) in 2015 to develop the former University City High School site, combined with the legacy campus along Market Street, rebranded as uCity Square. The partnership spans 20 buildings, 4.4M square feet, 15,000+ researchers, and 200 businesses. Wexford co-developed 3675 Market Street with the Science Center and Ventas.
• CIC PhiladelphiacoreStrategic or Co-development PartnerCIC Philadelphia operates state-of-the-art collaborative workspace across six floors at 3675 Market Street (private and shared lab space, offices, conference rooms, flexible 30-day terms). Many companies supported through the Science Center's commercialization programs take space at CIC. CIC refers early-stage companies to the ic@3401 incubator and serves as a mentor resource for FirstHand and workforce training programs. Joint programming and referrals are conducted regularly.
• Baker TillyminorImplementation/ SI/ Consulting PartnerDue diligence partner for the Capital Readiness Program, providing startups with guidance on financial, legal, technical, and operational due diligence expectations from investors.
• CozenminorImplementation/ SI/ Consulting PartnerDue diligence partner for the Capital Readiness Program, providing legal and operational guidance to startups preparing for investor scrutiny.
• Duane MorrisminorImplementation/ SI/ Consulting PartnerDue diligence partner for the Capital Readiness Program.
• GaingelsminorImplementation/ SI/ Consulting PartnerDue diligence partner for the Capital Readiness Program, providing investor perspective and healthcare startup expertise.
• Independence Blue Cross (IBX)minorImplementation/ SI/ Consulting PartnerDue diligence partner for the Capital Readiness Program, providing payor perspective on healthcare innovation value and reimbursement viability.
• KPMG USminorImplementation/ SI/ Consulting PartnerDue diligence partner for the Capital Readiness Program, providing financial and operational due diligence expertise.
• Virtua HealthminorImplementation/ SI/ Consulting PartnerDue diligence partner for the Capital Readiness Program, providing healthcare system and clinical operations perspective.
• NIH SEED OfficeminorImplementation/ SI/ Consulting PartnerDue diligence partner for the Capital Readiness Program, providing federal funding and small business innovation perspective.
• Penn Medicine (University of Pennsylvania Health System)coreStrategic or Co-development PartnerPenn Medicine leaders (including Brian Englander MD of Pennsylvania Hospital, Shiva Chandrasekaran MD of Lumeris, Patrick Mahanger of Penn Psychiatry, Robert Vonderheide MD of Abramson Cancer Center) regularly participate in Science Center Think Tank discussions, Capital Readiness Program panels, and provide clinical advisory. Siemens Healthineers partnered with Penn Medicine to host mobile mammogram events detecting cancers in underserved populations.
• Caring CrosscoreStrategic or Co-development PartnerMember of the BioCurie ARPA-H award consortium led by Science Center alumnus company. Caring Cross contributes to the AI-powered digital platform for scalable gene therapy manufacturing.
• St. Jude Children's Research HospitalcoreStrategic or Co-development PartnerMember of the BioCurie ARPA-H award consortium. St. Jude contributes to the AI-powered digital platform for scalable gene therapy manufacturing under the $9.3M ARPA-H award.
• Center for Breakthrough Medicines (SK pharmteco Cell & Gene US)coreStrategic or Co-development PartnerMember of the BioCurie ARPA-H award consortium. Contributes gene therapy manufacturing expertise to the AI platform development project. SK pharmteco acquired the Center for Breakthrough Medicine as noted in 2023 regional transactions.
• Siemens HealthineerscoreStrategic or Co-development PartnerSiemens Healthineers participated in Science Center Think Tank discussions (Christian Eusemann, VP Research and Innovation). Partnered with Penn Medicine to host 30 public mobile mammogram events in the Philadelphia community, completing nearly 400 screenings and detecting multiple cancers with treatment plans underway. Represents strategic collaboration on cancer care innovation.
• American Cancer SocietycoreStrategic or Co-development PartnerScience Center Think Tank featured Michael Marquardt (former CEO and board member of ACS). ACS runs 34 lodges and Road to Recovery volunteer driver program for cancer patients. ACS BrightEdge (innovation arm) is an advisory relationship through Adam Glasofer's Vertex Health clients.
• Venture Café Global InstitutecoreStrategic or Co-development PartnerVenture Café Philadelphia is operated by the Science Center as part of the Venture Café Global Network. The Science Center manages the Philadelphia chapter independently, with CIC as an active partner and contributor to programming. The global network spans multiple markets and began at CIC Cambridge over 10 years ago.
• HLTH FoundationcoreGTM or Marketing PartnerThe Science Center returns annually to HLTH USA (Las Vegas) with an expanded pavilion, announced expansion of its U.S. Market Access Program, and uses HLTH as a platform to spotlight its international startups and partners entering the U.S. healthcare market.
• U.S. Senatorial Staff (Senators Fetterman and McCormick)minorOthersThe Science Center hosted visits from Mikaela Witherspoon (Eastern Regional Director for U.S. Senator John Fetterman) and Chris Quinn (Southeastern Regional Director for U.S. Senator David H. McCormick) in September 2025, including campus tours and discussions aligning with Senators' priorities.
• ARPA-H (beyond BioCurie award)coreStrategic or Co-development PartnerARPA-H (represented by Craig Gravitz, Director of Project Accelerator Transition Innovation Office) participated in Science Center Think Tank discussions on AI in healthcare and nurse-driven innovation. ARPA-H Program Manager Daria Fedyukina Ph.D. leads the BioCurie project for the agency.
• Young Transatlantic Innovation Leaders Initiative (YTILI)minorStrategic or Co-development PartnerThe Science Center hosted two YTILI Fellows as part of the Young Transatlantic Innovation Leaders Initiative Fellowship Program — an opportunity for young European business professionals to expand networks and engage with the U.S. business sector.

Scale indicators20 records

Recent moves10 records

Expansion highlights8 records

Direct peers

• Cambridge Innovation Center (CIC): CIC operates co-working and lab space inside the Science Center's 3675 Market Street building and partners on programming and referrals. Both organizations run innovation district models with shared workspace, event space, and tenant services, making CIC the closest operational peer for facility-based innovation intermediation.
• MaRS Discovery District: MaRS is a large urban innovation district in Toronto supporting health, cleantech, and fintech startups through programs, advisory, and convening. Comparable to the Science Center as a multi-decade urban innovation intermediary combining programs, real estate, and ecosystem convening with a strong healthcare focus.
• MassChallenge: MassChallenge operates equity-free accelerator programs globally with a strong healthtech vertical and large alumni networks. Both organizations run cohort-based, no-equity programs targeting early-stage founders, but MassChallenge has broader geographic reach while the Science Center is regionally anchored.

Broad incumbents

• JLABS (Johnson & Johnson Innovation): JLABS operates a global network of life sciences incubators with no-equity residency models for early-stage biotech, medtech, and digital health startups. Comparable to the Science Center's Capital Readiness Program in serving medtech founders with clinical and commercialization support, but backed by Johnson & Johnson's resources and global footprint.
• Cleveland Clinic Innovations: Cleveland Clinic Innovations commercializes inventions from Cleveland Clinic clinicians and operates a healthcare venture fund. Comparable to the Science Center's Translation Project in bridging clinical innovation to commercial outcomes, but anchored to a single hospital system rather than a multi-institution ecosystem.

Regional players

• BioGenerator: BioGenerator is St. Louis's regional life sciences accelerator providing seed funding, lab space, and commercialization support to biotech startups. Comparable as a regional intermediary with both programs and capital, but operates in a different metro and uses a more capital-intensive (equity-taking) model.
• BioEnterprise: BioEnterprise (Cleveland) is a regional life sciences commercialization organization providing advisory, capital access, and programming to medtech and biotech startups. Comparable in mission to accelerate healthcare innovation in a specific region, though operates at smaller scale than the Science Center.

Others

• Wexford Science + Technology: Wexford is the Science Center's core real estate partner in uCity Square and co-develops knowledge communities across the U.S. While not a direct operational peer, Wexford's innovation district model is closely intertwined with the Science Center's programming and represents the real estate side of the same ecosystem play.
• Philadelphia Industrial Development Corporation (PIDC): PIDC is Philadelphia's public-private economic development corporation, partnering with the Science Center on life sciences industry growth. Comparable as a regional innovation and economic development intermediary, though with broader real estate and lending capabilities beyond the Science Center's program focus.

Emerging players

• Y Combinator: Y Combinator is the largest global accelerator, including a growing digital health vertical, offering seed capital, mentorship, and network access to early-stage founders. While operating at much larger scale and with an equity-taking model, YC competes for the same cohort of healthcare founders the Science Center serves through Capital Readiness.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/ucsciencecenter
• LinkedInlinkedin.com/company/science-center

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Funding overview

Funding rounds8 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments14 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Science Center